stars 1 stars 2 stars 3

Drossapharm Ltd. is an independent Swiss pharmaceutical company that develops, manufactures and markets medicinal products, most of which require a prescription. Drossapharm Ltd. specializes in specific indication areas and active principles. The product assortment includes drugs for treating rheumatic diseases, accident and sport injuries, venous and vascular complaints, as well as dermatologies and gynecological disturbances. Drossapharm Ltd. plays a leading role in these activities. Physicians, pharmacies and hospitals make up our customer base. With an innovative assortment of high-quality products, Drossapharm aims to satisfy the needs of the medical profession and patients.

Drossapharm Questions

The Drossapharm annual revenue was $22.5 million in 2026.

Valentin Stocker is the CFO of Drossapharm.

48 people are employed at Drossapharm.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users